The role of mitochondrial and plasma membrane nucleoside transporters in drug toxicity

George P.H. Leung, Chung Ming Tse

Research output: Contribution to journalReview articlepeer-review

Abstract

Many anticancer and antiviral drugs are nucleoside analogues, which interfere with nucleotide metabolism and DNA replication to produce pharmacological effects. Clinical efficacy and toxicity of nucleoside drugs are closely associated with nucleoside transporters because they mediate the transport of nucleoside drugs across biological membranes. Two families of human nucleoside transporters (equilibrative nucleoside transporters and concentrative nucleoside transporters) have been extensively studied for several decades. They are widely distributed, from the plasma membrane to membranes of organelles such as mitochondria, and the distribution differs in different tissues. In addition, they have different specificities to nucleoside drugs. The characteristics of equilibrative and concentrative nucleoside transporters affect the therapeutic outcomes achieved with anticancer and antiviral nucleoside drugs. In this review, an overview of the role of mitochondrial and plasma membrane nucleoside transporters in nucleoside drug toxicity is provided. Rational design and therapeutic application of nucleoside analogues are also discussed.

Original languageEnglish (US)
Pages (from-to)705-718
Number of pages14
JournalExpert Opinion on Drug Metabolism and Toxicology
Volume3
Issue number5
DOIs
StatePublished - Oct 2007

Keywords

  • Anticancer
  • Antiviral
  • Mitochondria
  • Nucleoside
  • Toxicity
  • Transporter

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Fingerprint

Dive into the research topics of 'The role of mitochondrial and plasma membrane nucleoside transporters in drug toxicity'. Together they form a unique fingerprint.

Cite this